• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Expansion of medical home program to Medicare patients not linked with improved quality or cost-reduction

byJames EnglandandAnees Daud
August 9, 2017
in Chronic Disease, Emergency, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. The “medical home” program by CareFirst is a commercial quality improvement initiative designed to improve care and reduce cost for patients treated by team-based “medical panels” of healthcare professionals. The expansion of this program to Medicare fee-for-service (FFS) patients did not demonstrate any improvement in quality metrics or cost savings.

2. More patients in the Medicare FFS population were identified as “high risk” than the standard commercial population.

Evidence Rating Level: 3 (Average)

Study Rundown: The increasing rise of healthcare costs remains a primary concern for many developed nations. Improvements in outpatient care are expected to be linked to lower rates of hospital and emergency services. The CareFirst program from BlueCross BlueShield is a “medical home” program that has demonstrated some efficacy at reducing hospitalizations through team-based approaches of care with “medical panels,” development and adherence to care pans, and financial incentives for meeting quality measures. The program specifically targets interventions to “high risk” patients. This study evaluated improvements in care quality and reduction in costs for panels that were expanded to care for Medicare FFS patients, compared to panels that remained commercial only. The study found no differences in rates of hospitalization, emergency department visits, or Medicare A and B spending.

The discrepancy in the program performance for Medicare patients could be that financial incentives were priced in a manner where the expected increase in cost for the comparison population was expected to have a greater increase. The Medicare population also had a greater frequency of “high risk” patients (60%) compared to the commercial population (11%) making it more difficult to focus resources on patients expected to have the greatest benefit.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Telehealth yields modest improvements in diabetes outcomes 

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

Relevant Reading: Early Impact Of CareFirst’s Patient-Centered Medical Home With Strong Financial Incentives

In-Depth [prospective cohort]: This study followed 14 medical panels included in the Medicare expansion in Maryland and evaluated their patients from 2012 to 2015, including a 1 year lead-in period. Commercial population-only panels were used as comparison cohorts. The main components of the intervention included: care coordination with nurses assigned to patients and care plans developed with the patient the healthcare professionals, financial incentives for developing and updating care plans and hitting care quality targets, technical assistance for quarterly reviews of cost and care gaps.

The patients in the intervention group had a mean age of 73.8 years, 59.2% were female, and 85.1% were white and 60% were considered to be in the top two risk groups. There were no differences in admissions, ED visits, ambulatory care follow up after discharge, or spending between the intervention and comparison groups.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: fee for servicemedicare
Previous Post

2 Minute Medicine Rewind August 7, 2017

Next Post

HCV treatment administered by nonspecialist providers as safe and effective as that provided by specialists

RelatedReports

Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
Patient outreach collage: an old desk telephone with a coiled cord, an open brass compass and a blank appointment card
Public Health

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

February 16, 2026
FDA-regulated clinical trials rarely report violations
All Specialties

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

September 4, 2026
Healthcare worker burnout collage: a tired male nurse in scrubs with his mask lowered beside a coronavirus particle
Public Health

Risk of financial precarity from hospitalization among Medicare beneficiaries ineligible for Medicaid

October 30, 2024
Next Post

HCV treatment administered by nonspecialist providers as safe and effective as that provided by specialists

Osteoporosis medications may improve bone health in men receiving androgen deprivation therapy for prostate cancer

Plasma Epstein–Barr virus DNA useful for nasopharyngeal carcinoma screening

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence-generated pre-visit summaries improved communication outcomes in neurosurgical consultations
  • Midline catheters may reduce catheter-related bloodstream infections compared with peripherally inserted central catheters in intensive care unit patients
  • AI scribe use associated with reduced documentation time but longer clinical notes
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.